|4Jul 5, 4:09 PM ET

Jin David 4

4 · AVENUE THERAPEUTICS, INC. · Filed Jul 5, 2023

Insider Transaction Report

Form 4
Period: 2023-06-30
Jin David
Int. PEO, Int. PFO, and COO
Transactions
  • Award

    Employee stock option (right to buy)

    2023-06-30+250,000250,000 total
    Exercise: $1.14Exp: 2033-06-30Common Stock (250,000 underlying)
Footnotes (2)
  • [F1]The option vests in accordance with the following schedule: (i) 25% of the shares subject to the option vest on August 1, 2023; (ii) 25% of the shares subject to the option vest on August 1, 2024; (iii) 25% of the shares subject to the option vest on August 1, 2025; and (iv) 25% of the shares subject to the option vest on August 1, 2026.
  • [F2]Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.

Documents

1 file
  • 4
    tm2320488d5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT